News about Global Pharma

Aurobindo Pharma Secures Final Approval for Rivaroxaban Tablets USP, 2.5mg

Aurobindo Pharma has received final USFDA approval to manufacture and market Rivaroxaban Tablets USP, 2.5 mg, the generic equivalent of XARELTO (2.5 mg). The company plans to launch it in Q1 FY26. It also received tentative approval for 10 mg, 15 mg, and 20 mg strengths.

Global Pharma | 14/04/2025 | By Manvi |  355

Zydus Secures Final Approval from USFDA for Jaythari (Deflazacort) Tablets in Multiple Dosages

Zydus Lifesciences Ltd. has received final USFDA approval to manufacture Jaythari (Deflazacort) Tablets in multiple strengths, a generic version of Emflaza, for the treatment of Duchenne muscular dystrophy.

Global Pharma | 14/04/2025 | By Manvi |  234

Amgen Reports Positive Interim Results for IMDELLTRA in Small Cell Lung Cancer Study

IMDELLTRA demonstrated statistically significant and clinically meaningful improvement in overall survival compared to local standard-of-care chemotherapy.

Global Pharma | 14/04/2025 | By Abha |  547

Taiwan MOHW Approves ACRO Biomedical's ABCcolla Collagen Ophthalmic Matrix

According to WHO, over 20 million people suffer from blindness due to corneal injuries or infections, yet only around 100,000 corneal transplants are performed annually, leading to a severe shortage.

Global Pharma | 14/04/2025 | By Abha |  354

Turbett Surgical Receives FDA 510(k) Clearance for Enhanced Instrument Pod Portfolio

Turbett Surgical's Instrument Pods receive FDA 510(k) clearance, boasting increased weight capacity of up to 300 lbs for the TS1200 and expanded lumen validation for improved surgical instrument management.

Global Pharma | 11/04/2025 | By Manvi |  585

Intrinsic Therapeutics Appoints Keith Valentine as President and Chief Executive Officer

Intrinsic Therapeutics, announced the appointment of Keith Valentine as President and Chief Executive Officer. Valentine will also join the Board of Directors and will begin his role in early May.

Global Pharma | 11/04/2025 | By Manvi |  313

Akums Drugs & Pharmaceuticals Embraces Sustainability with Rooftop Solar Plant in its Haridwar Warehouse

Akums Drugs & Pharmaceuticals Ltd. has installed a 600 kWp rooftop solar power plant at its warehouse in Haridwar, Uttarakhand marking a major step in its commitment to sustainability and clean energy adoption.

Global Pharma | 11/04/2025 | By Manvi |  660

Innoblative Wins FDA IDE Approval for SIRA Device, Advancing Breast Cancer Surgery Innovation

Innoblative's SIRA device is a single-use, disposable applicator built for intraoperative ablation of the post-lumpectomy cavity during breast conserving surgery.

Global Pharma | 11/04/2025 | By Abha |  594

Novartis Unveils USD 23 Billion US Investment to Boost Domestic Drug Manufacturing and Research

Over the next 5 years, Novartis will establish 1 biomedical research innovation hub in San Diego, CA, its second global R&D hub in the US.

Global Pharma | 11/04/2025 | By Abha |  738

Biocon Biologics Announces USFDA Approval of JOBEVNE Biosimilar for Cancer Treatment

Biocon Biologics Ltd (BBL), a subsidiary of Biocon Ltd announced that the US Food and Drug Administration (USFDA) has approved Jobevne™ (bevacizumab-nwgd), a biosimilar Bevacizumab for intravenous use.

Global Pharma | 10/04/2025 | By Manvi |  492